ruxolitinib
incyte,novartis
['ovarian', 'gyn', 'ruxolitinib']
 the phase ii of addition of ruxolitinib to chemotherapy revealed improved progression free survival for pts with #ovariancancer in this small exploratory study. #asco22 #gyncsm 
Gyn Onc at MD Anderson. She/Hers. Wife of @DrJasonWestin. Innovative clinical trials. #JCO social media editor. Opinions=mine.
https://t.co/QLXLDKSThc